More than 50% of cases of T-ALL involve somatic activating mutations of Notch1 [2], a potent regulator known to play an oncogenic role in many malignancies, affecting proliferation, invasion, chemoresistance, angiogenesis and cell fate determination [3-5]. This evidence concerns the gene NOTCH1 and acute lymphoblastic leukemia.